30 related articles for article (PubMed ID: 7923171)
1. SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid.
Haggagy MG; Ahmed LA; Sharaky M; Elhefnawi MM; Omran MM
Sci Rep; 2024 Jan; 14(1):41. PubMed ID: 38167952
[TBL] [Abstract][Full Text] [Related]
2. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
Legrier ME; Bièche I; Gaston J; Beurdeley A; Yvonnet V; Déas O; Thuleau A; Château-Joubert S; Servely JL; Vacher S; Lassalle M; Depil S; Tucker GC; Fontaine JJ; Poupon MF; Roman-Roman S; Judde JG; Decaudin D; Cairo S; Marangoni E
Br J Cancer; 2016 Jan; 114(2):177-87. PubMed ID: 26695443
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance and DNA repair in leukaemia.
Müller MR; Thomale J; Rajewsky MF; Seeber S
Cytotechnology; 1998 Sep; 27(1-3):175-85. PubMed ID: 19002791
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression in busulfan-resistant human myeloid leukemia.
Valdez BC; Murray D; Ramdas L; de Lima M; Jones R; Kornblau S; Betancourt D; Li Y; Champlin RE; Andersson BS
Leuk Res; 2008 Nov; 32(11):1684-97. PubMed ID: 18339423
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and pharmacokinetics of oxazaphosphorines.
Boddy AV; Yule SM
Clin Pharmacokinet; 2000 Apr; 38(4):291-304. PubMed ID: 10803453
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.
Friedman HS; Johnson SP; Colvin OM
Cancer Treat Res; 2002; 112():199-209. PubMed ID: 12481718
[No Abstract] [Full Text] [Related]
7. Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line.
Andersson BS; Mroue M; Britten RA; Farquhar D; Murray D
Acta Oncol; 1995; 34(2):247-51. PubMed ID: 7718264
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs.
Andersson BS; Sadeghi T; Siciliano MJ; Legerski R; Murray D
Cancer Chemother Pharmacol; 1996; 38(5):406-16. PubMed ID: 8765433
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Tsukamoto N; Chen J; Yoshida A
Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
Crook TR; Souhami RL; Whyman GD; McLean AE
Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
[TBL] [Abstract][Full Text] [Related]
11. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
Richardson ME; Siemann DW
Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
[TBL] [Abstract][Full Text] [Related]
12. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
Andersson BS; Mroue M; Britten RA; Murray D
Cancer Res; 1994 Oct; 54(20):5394-400. PubMed ID: 7923171
[TBL] [Abstract][Full Text] [Related]
13. Model studies of cyclophosphamide resistance in human myeloid leukemia.
Andersson BS; Murray D
Cancer Treat Res; 2002; 112():211-35. PubMed ID: 12487104
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
